US FDA approves obesity drug Wegovy: Safety, efficacy and side effects

According to the US Food and Drug Administration (FDA), the safety and efficacy of Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, were studied in four 68-week trials.